Using an ELISA-based assay from the tumor tissue extracts, Kuhn et al. demonstrated that both uPA and PAI-1 have prognostic significance in predicting overall survival of the patients who have advanced ovarian cancer stage FIGO IIIc (161). This evidence concerns the gene PLAU and ovarian cancer.